Gamble Jones Investment Counsel Bristol Myers Squibb CO Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 68,103 shares of BMY stock, worth $3.62 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

68,103

Previous 68,128 0.04%

Holding current value

$3.62 Million

Previous $4.84 Million 1.16%

% of portfolio

0.37%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $1,712 - $2,027	-25 Reduced 0.04%	68,103 $4.9 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $390 - $230,520	-3,000 Reduced 4.22%	68,128 $4.84 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $679,723 - $748,612	-9,360 Reduced 11.63%	71,128 $5.48 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $13,833 - $16,587	-225 Reduced 0.28%	80,488 $5.88 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $192,102 - $223,946	-3,582 Reduced 4.25%	80,713 $5.03 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $2,958 - $3,465	-50 Reduced 0.06%	84,295 $4.99 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $3,095 - $3,371	50 Added 0.06%	84,345 $5.64 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $25,219 - $28,364	-425 Reduced 0.5%	84,295 $5.32 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $529,879 - $600,451	-9,177 Reduced 9.77%	84,720 $5.26 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $52,031 - $57,657	-906 Reduced 0.96%	93,897 $5.66 Million
Q2 2020 Aug 19, 2020	SELL	$54.82 - $64.09 $12,060 - $14,099	-220 Reduced 0.23%	94,803 $5.57 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $122,449 - $177,947	-2,639 Reduced 2.7%	95,023 $5.3 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $56,394 - $73,561	-1,146 Reduced 1.16%	97,662 $6.27 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $103,075 - $122,211	-2,410 Reduced 2.38%	98,808 $5.01 Million
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $58,273 - $64,438	-1,306 Reduced 1.27%	101,218 $4.59 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $90,240 - $107,600	-2,000 Reduced 1.91%	102,524 $4.89 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $93,765 - $121,591	-1,923 Reduced 1.81%	104,524 $5.43 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $18,488 - $20,853	-335 Reduced 0.31%	106,447 $6.61 Million
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $63,162 - $78,725	-1,250 Reduced 1.16%	106,782 $5.91 Million
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $42,842 - $49,320	-715 Reduced 0.66%	108,032 $6.83 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $119,820 - $130,634	-1,999 Reduced 1.81%	108,747 $6.66 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $6.12 Million - $7.06 Million	110,746	110,746 $7.06 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Bristol Myers Squibb CO Transaction History